Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 143

1.

The Capacity of the Fecal Microbiota From Malawian Infants to Ferment Resistant Starch.

Wang Y, Mortimer EK, Katundu KGH, Kalanga N, Leong LEX, Gopalsamy GL, Christophersen CT, Richard AC, Shivasami A, Abell GCJ, Young GP, Rogers GB.

Front Microbiol. 2019 Jun 26;10:1459. doi: 10.3389/fmicb.2019.01459. eCollection 2019.

2.

A Randomized Controlled Trial Testing Provision of Fecal and Blood Test Options on Participation for Colorectal Cancer Screening.

Symonds EL, Hughes D, Flight I, Woodman R, Chen G, Ratcliffe J, Pedersen SK, Fraser RJL, Wilson CJ, Young GP.

Cancer Prev Res (Phila). 2019 Sep;12(9):631-640. doi: 10.1158/1940-6207.CAPR-19-0089. Epub 2019 Jul 2.

PMID:
31266825
3.

Resistant Starch is Actively Fermented by Infant Faecal Microbiota and Increases Microbial Diversity.

Gopalsamy G, Mortimer E, Greenfield P, Bird AR, Young GP, Christophersen CT.

Nutrients. 2019 Jun 14;11(6). pii: E1345. doi: 10.3390/nu11061345.

4.

Low Sensitivity of Fecal Immunochemical Tests and Blood-Based Markers of DNA Hypermethylation for Detection of Sessile Serrated Adenomas/Polyps.

Cock C, Anwar S, Byrne SE, Meng R, Pedersen S, Fraser RJL, Young GP, Symonds EL.

Dig Dis Sci. 2019 Sep;64(9):2555-2562. doi: 10.1007/s10620-019-05569-8. Epub 2019 Mar 5.

PMID:
30835026
5.

Reducing the number of surveillance colonoscopies with faecal immunochemical tests.

Symonds EL, Cornthwaite K, Fraser RJL, Bampton P, Cock C, Young GP.

Gut. 2019 Feb 26. pii: gutjnl-2019-318370. doi: 10.1136/gutjnl-2019-318370. [Epub ahead of print] No abstract available.

PMID:
30808647
6.

The Global Paradigm Shift in Screening for Colorectal Cancer.

Young GP, Rabeneck L, Winawer SJ.

Gastroenterology. 2019 Mar;156(4):843-851.e2. doi: 10.1053/j.gastro.2019.02.006. Epub 2019 Feb 16. No abstract available.

PMID:
30776340
7.

The significance of the small adenoma: a longitudinal study of surveillance colonoscopy in an Australian population.

Symonds EL, Cole SR, Lau SY, Steele S, Meng R, Woodman RJ, Young GP, Cock C, Fraser R, Bampton P.

Eur J Gastroenterol Hepatol. 2019 May;31(5):563-569. doi: 10.1097/MEG.0000000000001358.

PMID:
30672827
8.

The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens.

Osborne JM, Flight I, Wilson CJ, Chen G, Ratcliffe J, Young GP.

Patient Prefer Adherence. 2018 Sep 18;12:1825-1836. doi: 10.2147/PPA.S172143. eCollection 2018.

9.

Effects of Dietary Fibre from the Traditional Indonesian Food, Green Cincau (Premna oblongifolia Merr.) on Preneoplastic Lesions and Short Chain Fatty Acid Production in an Azoxymethane Rat Model of Colon Cancer.

Nurdin SU, Le Leu RK, Aburto-Medina A, Young GP, Stangoulis JCR, Ball AS, Abbott CA.

Int J Mol Sci. 2018 Aug 31;19(9). pii: E2593. doi: 10.3390/ijms19092593.

10.

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers.

Saluja H, Karapetis CS, Pedersen SK, Young GP, Symonds EL.

Front Oncol. 2018 Jul 24;8:275. doi: 10.3389/fonc.2018.00275. eCollection 2018. Review.

11.

Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival.

Murray DH, Symonds EL, Young GP, Byrne S, Rabbitt P, Roy A, Cornthwaite K, Karapetis CS, Pedersen SK.

J Cancer Res Clin Oncol. 2018 Sep;144(9):1741-1750. doi: 10.1007/s00432-018-2701-x. Epub 2018 Jul 10.

PMID:
29992492
12.

World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer.

Rutter MD, Beintaris I, Valori R, Chiu HM, Corley DA, Cuatrecasas M, Dekker E, Forsberg A, Gore-Booth J, Haug U, Kaminski MF, Matsuda T, Meijer GA, Morris E, Plumb AA, Rabeneck L, Robertson DJ, Schoen RE, Singh H, Tinmouth J, Young GP, Sanduleanu S.

Gastroenterology. 2018 Sep;155(3):909-925.e3. doi: 10.1053/j.gastro.2018.05.038. Epub 2018 Jun 27.

13.

Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection.

Symonds EL, Pedersen SK, Murray DH, Jedi M, Byrne SE, Rabbitt P, Baker RT, Bastin D, Young GP.

Clin Epigenetics. 2018 May 16;10:63. doi: 10.1186/s13148-018-0500-5. eCollection 2018.

14.

Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues.

Jedi M, Young GP, Pedersen SK, Symonds EL.

Clin Med Insights Oncol. 2018 May 10;12:1179554918775064. doi: 10.1177/1179554918775064. eCollection 2018.

15.

Demand for Colonoscopy in Colorectal Cancer Screening Using a Quantitative Fecal Immunochemical Test and Age/Sex-Specific Thresholds for Test Positivity.

Chen SL, Hsu CY, Yen AM, Young GP, Chiu SY, Fann JC, Lee YC, Chiu HM, Chiou ST, Chen HH.

Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):704-709. doi: 10.1158/1055-9965.EPI-17-0387. Epub 2018 Mar 28.

16.

Web-Based Communication Strategies Designed to Improve Intention to Minimize Risk for Colorectal Cancer: Randomized Controlled Trial.

Wilson C, Flight I, Zajac IT, Turnbull D, Young GP, Olver I.

JMIR Cancer. 2018 Feb 12;4(1):e2. doi: 10.2196/cancer.8250.

17.

Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?

Osborne JM, Wilson C, Duncan A, Cole SR, Flight I, Turnbull D, Hughes DL, Young GP.

BMC Public Health. 2017 Aug 1;18(1):81. doi: 10.1186/s12889-017-4634-8. Erratum in: BMC Public Health. 2017 Sep 22;17 (1):736.

18.

Findings in young adults at colonoscopy from a hospital service database audit.

Wong S, Lidums I, Rosty C, Ruszkiewicz A, Parry S, Win AK, Tomita Y, Vatandoust S, Townsend A, Patel D, Hardingham JE, Roder D, Smith E, Drew P, Marker J, Uylaki W, Hewett P, Worthley DL, Symonds E, Young GP, Price TJ, Young JP.

BMC Gastroenterol. 2017 Apr 19;17(1):56. doi: 10.1186/s12876-017-0612-y.

19.

Drug-development concepts as guides for optimizing clinical trials of supplemental zinc for populations at risk of deficiency or diarrhea.

Alpers DH, Young GP, Tran CD, Mortimer EK, Gopalsamy GL, Krebs NF, Manary MJ, Ramakrishna BS, Binder HJ, Brown IL, Miller LV.

Nutr Rev. 2017 Mar 1;75(3):147-162. doi: 10.1093/nutrit/nuw065. Review.

PMID:
28399577
20.

Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.

Symonds EL, Cock C, Meng R, Cole SR, Fraser RJL, Young GP.

Eur J Cancer Prev. 2018 Sep;27(5):425-432. doi: 10.1097/CEJ.0000000000000352.

PMID:
28368949

Supplemental Content

Loading ...
Support Center